SPARTOO (ALSPT.PA) Fundamental Analysis & Valuation

EPA:ALSPT • FR00140043Y1

Current stock price

0.23 EUR
-0.01 (-3.77%)
Last:

This ALSPT.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. ALSPT.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALSPT has reported negative net income.
  • In the past year ALSPT had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: ALSPT reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: ALSPT reported negative operating cash flow in multiple years.
ALSPT.PA Yearly Net Income VS EBIT VS OCF VS FCFALSPT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 5M -5M -10M -15M -20M

1.2 Ratios

  • With a Return On Assets value of -2.58%, ALSPT is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
  • Looking at the Return On Equity, with a value of -7.11%, ALSPT is doing worse than 66.67% of the companies in the same industry.
  • The Return On Invested Capital of ALSPT (11.65%) is better than 79.63% of its industry peers.
Industry RankSector Rank
ROA -2.58%
ROE -7.11%
ROIC 11.65%
ROA(3y)-3.05%
ROA(5y)-1%
ROE(3y)-9.05%
ROE(5y)-1.75%
ROIC(3y)N/A
ROIC(5y)N/A
ALSPT.PA Yearly ROA, ROE, ROICALSPT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

  • ALSPT has a better Operating Margin (5.49%) than 66.67% of its industry peers.
  • ALSPT's Operating Margin has improved in the last couple of years.
  • ALSPT has a better Gross Margin (50.85%) than 72.22% of its industry peers.
  • In the last couple of years the Gross Margin of ALSPT has remained more or less at the same level.
Industry RankSector Rank
OM 5.49%
PM (TTM) N/A
GM 50.85%
OM growth 3Y26.27%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.43%
GM growth 5YN/A
ALSPT.PA Yearly Profit, Operating, Gross MarginsALSPT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 10 20 30 40 50

5

2. ALSPT.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ALSPT is creating value.
  • The number of shares outstanding for ALSPT has been increased compared to 1 year ago.
  • Compared to 1 year ago, ALSPT has an improved debt to assets ratio.
ALSPT.PA Yearly Shares OutstandingALSPT.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M
ALSPT.PA Yearly Total Debt VS Total AssetsALSPT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • An Altman-Z score of 1.85 indicates that ALSPT is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • ALSPT has a Altman-Z score of 1.85. This is comparable to the rest of the industry: ALSPT outperforms 50.00% of its industry peers.
  • ALSPT has a debt to FCF ratio of 3.27. This is a good value and a sign of high solvency as ALSPT would need 3.27 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.27, ALSPT is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • A Debt/Equity ratio of 0.44 indicates that ALSPT is not too dependend on debt financing.
  • The Debt to Equity ratio of ALSPT (0.44) is better than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 3.27
Altman-Z 1.85
ROIC/WACC2.16
WACC5.4%
ALSPT.PA Yearly LT Debt VS Equity VS FCFALSPT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

  • ALSPT has a Current Ratio of 1.95. This is a normal value and indicates that ALSPT is financially healthy and should not expect problems in meeting its short term obligations.
  • ALSPT's Current ratio of 1.95 is fine compared to the rest of the industry. ALSPT outperforms 79.63% of its industry peers.
  • ALSPT has a Quick Ratio of 1.95. This is a bad value and indicates that ALSPT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ALSPT has a Quick ratio (0.65) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.95
Quick Ratio 0.65
ALSPT.PA Yearly Current Assets VS Current LiabilitesALSPT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M

2

3. ALSPT.PA Growth Analysis

3.1 Past

  • ALSPT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -57.86%.
  • ALSPT shows a decrease in Revenue. In the last year, the revenue decreased by -7.50%.
  • Measured over the past years, ALSPT shows a decrease in Revenue. The Revenue has been decreasing by -4.60% on average per year.
EPS 1Y (TTM)-57.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.57%
Revenue 1Y (TTM)-7.5%
Revenue growth 3Y-4.6%
Revenue growth 5YN/A
Sales Q2Q%-8.19%

3.2 Future

  • Based on estimates for the next years, ALSPT will show a very strong growth in Earnings Per Share. The EPS will grow by 20.51% on average per year.
  • ALSPT is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -2.67% yearly.
EPS Next Y50%
EPS Next 2Y32.29%
EPS Next 3Y20.51%
EPS Next 5YN/A
Revenue Next Year-8.47%
Revenue Next 2Y-4.21%
Revenue Next 3Y-2.67%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALSPT.PA Yearly Revenue VS EstimatesALSPT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
ALSPT.PA Yearly EPS VS EstimatesALSPT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 -0.2 -0.3

3

4. ALSPT.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALSPT. In the last year negative earnings were reported.
  • Also next year ALSPT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALSPT.PA Price Earnings VS Forward Price EarningsALSPT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALSPT indicates a rather cheap valuation: ALSPT is cheaper than 98.15% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, ALSPT is valued cheaper than 98.15% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.79
EV/EBITDA 0.74
ALSPT.PA Per share dataALSPT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • ALSPT's earnings are expected to grow with 20.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.29%
EPS Next 3Y20.51%

0

5. ALSPT.PA Dividend Analysis

5.1 Amount

  • No dividends for ALSPT!.
Industry RankSector Rank
Dividend Yield 0%

ALSPT.PA Fundamentals: All Metrics, Ratios and Statistics

SPARTOO

EPA:ALSPT (4/2/2026, 7:00:00 PM)

0.23

-0.01 (-3.77%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners35.61%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.20M
Revenue(TTM)125.12M
Net Income(TTM)-2.05M
Analysts84.44
Price Target1.12 (386.96%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)37.5%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)60%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.04%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF 0.79
P/OCF 0.72
P/B 0.15
P/tB 0.18
EV/EBITDA 0.74
EPS(TTM)-0.11
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)0.29
FCFY126.87%
OCF(TTM)0.32
OCFY139.31%
SpS6.84
BVpS1.58
TBVpS1.31
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.58%
ROE -7.11%
ROCE 15.85%
ROIC 11.65%
ROICexc 15.48%
ROICexgc 18.18%
OM 5.49%
PM (TTM) N/A
GM 50.85%
FCFM 4.26%
ROA(3y)-3.05%
ROA(5y)-1%
ROE(3y)-9.05%
ROE(5y)-1.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y13.91%
ROICexgc growth 5YN/A
ROICexc growth 3Y13.21%
ROICexc growth 5YN/A
OM growth 3Y26.27%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.43%
GM growth 5YN/A
F-Score6
Asset Turnover1.58
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 3.27
Debt/EBITDA 0.86
Cap/Depr 6.61%
Cap/Sales 0.42%
Interest Coverage 250
Cash Conversion 39.62%
Profit Quality N/A
Current Ratio 1.95
Quick Ratio 0.65
Altman-Z 1.85
F-Score6
WACC5.4%
ROIC/WACC2.16
Cap/Depr(3y)16.79%
Cap/Depr(5y)31.52%
Cap/Sales(3y)0.76%
Cap/Sales(5y)1.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.57%
EPS Next Y50%
EPS Next 2Y32.29%
EPS Next 3Y20.51%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.5%
Revenue growth 3Y-4.6%
Revenue growth 5YN/A
Sales Q2Q%-8.19%
Revenue Next Year-8.47%
Revenue Next 2Y-4.21%
Revenue Next 3Y-2.67%
Revenue Next 5YN/A
EBIT growth 1Y123.29%
EBIT growth 3Y20.46%
EBIT growth 5YN/A
EBIT Next Year363.16%
EBIT Next 3Y62.81%
EBIT Next 5YN/A
FCF growth 1Y135.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y142.61%
OCF growth 3YN/A
OCF growth 5YN/A

SPARTOO / ALSPT.PA Fundamental Analysis FAQ

What is the fundamental rating for ALSPT stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALSPT.PA.


What is the valuation status of SPARTOO (ALSPT.PA) stock?

ChartMill assigns a valuation rating of 3 / 10 to SPARTOO (ALSPT.PA). This can be considered as Overvalued.


What is the profitability of ALSPT stock?

SPARTOO (ALSPT.PA) has a profitability rating of 3 / 10.


How financially healthy is SPARTOO?

The financial health rating of SPARTOO (ALSPT.PA) is 5 / 10.